The Design of a Control System for a Type of Automatic Freezing Tray Machine

为一种新型冷冻盘自动加工机设计一套完整的控制系统.对该冷冻盘机的液压系统和电气系统进行了详细分析,给出了具体的软、硬件实现办法,将液压控制和PlC控制相结合,能够实现冷冻盘的全自动生产.实际应用表明:该机的控制系统工作可靠,能完全满足产品的规格要求.A control system was designed for a novel type of automatic freezing tray machine.The control system,by combining hydraulic control and PLC control,could realize the completely automatic operation of the freezing tray.In the mean time,the hydraulic system and electrical system of the freezing tray machine were studied and designed in detail.Real applications showed that the control system was reliable,and could meet all the specific requirements of the products

基于移动互联网的公共交通车辆轮胎养护平台与大数据分析

本文通过阐述如何建立轮胎专家数据库,怎样应用车联网传感器和移动互联网技术,又如何借助轮胎异常预警算法,为城市公交公司管理者、工程师和驾驶员提供一整套行之有效的解决方案。公交车是城市公共交通运输体系中的重要一环,甚至可以说是最重要的一环。它承担的公共交通任务是,为尽可能多的市民提供安全、实惠的城市出行选择。因为涉及的市民数量大,承担的客运任

九龙江流域地表水锰的污染来源和迁移转化机制

锰是人体必需微量元素,但近年来河流湖库等地表水锰超标现象时有发生,威胁供水安全.本文于2016—2017年在福建省九龙江流域开展水系沿程梯度调查及机理实验,结合历史监测资料综合研究,探明九龙江锰含量的时空分布与迁移转化规律,揭示九龙江锰的污染来源、超标成因与调控机制.结果表明,溶解锰高值及超标站位集中在北溪上游矿区支流和干流部分水库,且主要发生在枯水期;上游矿区支流颗粒锰含量最高,随后从上游到下游沿程递减,且与总悬浮颗粒物(TSM)和pH显著正相关(p7.8)环境促进亚热带红壤颗粒富集锰,大量富锰颗粒进入pH逐渐下降的河流下游和电站库区后向溶解锰转化,从而导致锰超标.河流下游及库区pH值下降的主要原因包括酸沉降、酸性废水排放、富营养化条件下有机物分解等.研究结果为我国地表水锰污染防控、饮用水安全保障与流域水环境综合管理提供科学依据.国家重点研发计划(No.2016YFC0502901);;福建省环保科技计划项目(No.2016R017)~

Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease

观察栀子苷改善非酒精性脂肪性肝病的效果,从游离脂肪酸探讨栀子苷调节非酒精性脂肪性肝病的作用机制。健康雄性Wistar大鼠40只,随机分为4组:正常组、模型组、栀子苷组和血脂康组,每组大鼠10只,正常组大鼠给予正常大鼠饲料喂养,其余3组大鼠均采用高脂饲料喂养以诱导非酒精性脂肪性肝病,造模时间为8周,从第5周起至第8周末,栀子苷组和血脂康组分别灌服相应的药物。记录大鼠体重、肝湿重、脂肪质量;用相应方法检测肝组织TG,FFA,FAS,AMPK,ACCase及Malonyl-Co A含量,血清CHO,LDL-C的含量,血清AST,ALT的活性;观察肝脏组织肉眼及病理变化(HE染色法)。结果显示,与正常组相比,模型组大鼠的体重;肝湿重;脂肪重;血清CHO,LDL-C,ALT,AST;肝组织TG,FFA,FAS,ACCase及Malonyl-Co A含量皆显著升高(P<0.01);肝组织AMPK活性显著降低(P<0.01),肝组织肉眼外观及病理切片脂肪变性明显,并出现炎症损伤;与模型组相比,栀子苷组大鼠体重、脂肪质量、肝组织FFA含量、血清ALT,AST活性均显著降低(P<0.01),肝湿重,肝组织TG,FAS,ACCase及Malonyl-Co A含量明显降低(P<0.05),肝组织AMPK活性明显增多(P<0.05),肝脏肉眼外观及病理学表现均有所改善;与模型组相比,血脂康组大鼠的肝湿重、脂肪质量、肝组织TG,FFA和血清LDL-C水平明显降低(P<0.05);与血脂康组相比,栀子苷组大鼠的体重、脂肪质量、肝组织FFA含量均显著降低(P<0.01),其他方面无明显差异。结果表明,栀子苷具有显著的改善高脂饮食诱导的大鼠非酒精性脂肪性肝病的药理效应;其改善大鼠非酒精性脂肪性肝病的游离脂肪酸代谢是通过调节"AMPK-ACCase-Malonyl-Co A-FFA"轴来实现的。To observe the effect of geniposide on non-alcoholic fatty liver disease( NAFLD),and discuss the mechanism of geniposide for NAFLD from the aspect of free fatty acid,forty healthy Wistar male rats were randomly divided into normal group,model group,geniposide and Xuezhikang group. The rats in normal group were fed with normal diets,and the rats in other 3 groups were given with high-fat diet for 8 weeks to induce the NAFLD models. From the week 5 to end of week 8,the rats in geniposide and Xuezhikang group were intervened with corresponding medicines. The body weight,liver wet weight,and fat weight of the rats were recorded.Visual and pathological changes in hepatic tissues were observed with HE staining. The contents of TG,FFA,FAS,AMPK,ACCase and Malonyl-Co A in hepatic tissue,contents of CHO and LDL-C in serum and activities of AST and ALT in serum were detected by using corresponding methods. The results showed that the body weight,liver wet weight,and fat weight of the rats,CHO,LDL-C,ALT and AST levels in serum,TG,FFA,FAS,ACCase and Malonyl-Co A levels in hepatic tissues of the rats in model group were significantly higher than those in normal group( P < 0. 01),while AMPK activity was significantly lower than that of the normal group( P < 0. 01),with obvious visual and pathological steatosis in hepatic tissues,and inflammatory injury occurred in model group. Compared with the model group,body weight of the rat,fat weight,levels of FFA in hepatic tissues,ALT and AST activities in serum,liver wet weight,TG,FAS,ACCase and Malonyl-Co A levels were significantly decreased in geniposide group( P < 0. 01),while the AMPK activity in hepatic tissues was significantly increased( P < 0. 05),with improvement in visual and pathological performance.Compared with the model group,liver wet weight,fat weight,TG and FFA levels in hepatic tissues,and LDL-C level in serum were significantly decreased in Xuezhikang group( P < 0. 05). Compared with Xuezhikang group,the body weight of rat,fat weight and FFA level in hepatic tissues were significantly lower in geniposide group( P < 0. 01),but with no significant difference in other aspects. These findings indicated that geniposide was highly effective in improving the pharmacological effect of NAFLD induced by highfat diet,and the mechanism was achieved through AMPK-ACCase-Malonyl-Co A-FFA axis.国家自然科学基金项目(81274155;81503529);; 福建省自然科学基金项目(2014J01374);; 福建省高等学校新世纪人才计划项目;; 厦门市科技计划项目(3502Z20134020);; 福建省中医药科研项目(WZPW201308

Clinical Research of Kangshi Kangxian Recipe Treating on Hepatic Fibrosis of Chronic Hepatitis B

目的观察康氏抗纤方治疗慢性乙型肝炎肝纤维化的临床疗效,探讨其对肝组织N-花生四烯酸氨基乙醇(; arachidonoylethanolamine,AEA) 、2-花生四烯酸甘油( 2-arachidonoylglycerol,2-AG); 、大麻素受体1( cannabinoid receptor 1,CBR1) mRNA、大麻素受体2( cannabinoid receptor; 1,CBR2); mRNA含量变化的影响。方法将110例慢性乙型肝炎肝纤维化患者按随机数字表法分为治疗组和对照组,每组55例。治疗组予中药康氏抗纤方联合恩替卡韦分; 散片治疗,对照组用恩替卡韦分散片单药治疗,两组均治疗48周。判定两组临床疗效,检测血清ALT水平,HBV; DNA、HBsAg、HBsAb定量,肝组织病理、肝硬度变化,肝组织AEA、 2-AG含量和CBR1、CBR2; mRNA表达水平。结果与对照组比较,治疗组的临床总有效率、HBsAg阴转率、肝组织纤维化分期疗效有效率均高于对照组(chi~2 =; 4.453,4.152,6.364,均P < 0.05); 。与本组治疗前比较,治疗后两组患者肝纤维化瞬时弹性测定值、AEA、2-AG含量及CBR1、CBR2 mRNA表达均降低(均P <; 0.05),且治疗组降低更明显(均P < 0.05); 。肝组织病理显示:治疗后治疗组肝小叶结构基本完整,肝细胞轻度水样变性,汇管区纤维组织无增生,局部少量淋巴细胞浸润,炎症及纤维化较对照组明显改善。; 结论康氏抗纤方具有提高慢性乙型肝炎肝纤维化患者的临床总有效率、HBsAg阴转率、肝组织纤维化分期疗效有效率,其作用机制可能与调节内源性大麻素系统; 有关。Objective To observe the clinical effect of Kangshi Kangxian Decoction (; KSKXD) in treating on patients of hepatic fibrosis of chronic hepatitis; B ( CHB),and to explore the mechanisms of KSKXD by regulating the; contents of arachidonoylethanolamine ( AEA),2-arachidonoylglycerol (; 2-AG),cannabinoid receptor 1 ( CBR1 mRNA) and cannabinoid receptor 2 (; CBR2 mRNA) in the liver tissue. Methods Totally 110 patients with; hepatic fibrosis of CHB were assigned to the treatment group and the; control group according to random digit table,55 cases in each group.; The treatment group was treated with Chinese herb KSKXD combined with; Entecavir,and the control group was treated with Entecavir. Both of the; two groups were treated for 48 weeks. The clinical efficacy of the two; groups was determined. The serum ALT levels,HBV DNA, HBsAg and HBsAb; quantification,liver pathological changes,liver stiffness; changes,contents of AEA and 2-AG,mRNA expression of CBR1 and CBR2 in the; liver tissue were detected. Results The total effective rate,HBsAg; negative conversion rate,hepatic fibrosis staging and curative effect; rate of the treatment group were higher than those of the control group; (chi~2 = 4.453,4.152,6.364,allP <0.05). After treatment,the; instantaneous elasticity of liver fibrosis,the contents of AEA and; 2-AG,the mRNA expressions of CBR1 and CBR2 in the liver tissue in the; two groups were decreased compared to those of the same group before; treatment (P < 0.05),and the treatment group had better effect than that; of the control group (P < 0.05). The pathological changes in the; treatment group after treatment indicated the liver lobules; integrity,mild hydropic degeneration of liver cells,periportal fibrous; tissue hyperplasia,local small lymphocytic infiltration,which fibrosis; and inflammation were better than those of the control group.; Conclusions KSKXD was effective in the treatment of hepatic fibrosis of; CHB, which improved total effective rate,HBsAg seroconversion rate and; liver fibrosis stage efficiency. And its mechanism maybe related to the; regulation of the endocannabinoid system.国家自然科学基金资助项目; 福建省科技计划引导性项目; 厦门市科技惠民项目; 福建中医药大学临床专项校管课题基

PCR-探针熔解分析法检测结核分枝杆菌利福平耐药性的临床应用

目的评价PCR-探针熔解分析法(probe melting analysis assay,PMAA)检测结核分枝杆菌(Mycobacterium tuberculosis,MTB)对利福平(rifampin,RFP)耐药性的临床应用价值。方法采用常规比例法和PCR-PMAA对512株MTB临床分离株进行RFP药敏试验,并进行RFP耐药相关基因rpoB DNA测序。结果以常规比例法为标准,PCR-PMAA检测RFP耐药性的敏感性、特异性分别为97.5%、96.2%,阳性和阴性预测值分别为94.1%、98.4%、符合率及约登指数分别为96.7%及0.93。193株比例法和PCR-PMAA两法检测均耐药的菌株,经DNA测序证实174株rpoB基因RFP耐药决定区(RFP resistance determining region,RRDR)发生单位点密码子突变,19株RRDR发生不同组合型的双位点密码子联合突变;5株比例法检出耐药、PCR-PMAA敏感的菌株,DNA测序rpoB基因未见突变;12株比例法检出敏感、PCR-PMAA耐药的菌株,DNA测序证实其中7株511位点密码子突变,5株533位点密码子突变;302株两法检测均敏感菌株DNA测序结果未见rpoB耐药相关的基因位点突变。PCR-PMAA检测MTB临床分离株rpoB基因突变结果与DNA测序结果完全一致。结论 PCR-PMAA法能高效检出MTB对RFP耐药的相关基因突变,用于检测MTB对RFP耐药性的敏感性高、特异性强,方法简便、快速、价廉,具有良好的临床应用前景

Essence of tongue diagnosis of HE Meng-yao

岭南,指中国五岭以南的地区,相当于现在广东、广西及海南全境。因气候炎热潮湿,人群多脾胃虚弱,病多阳虚、痰湿。从晋代以后,当地医家以中原医学为基础; ,结合岭南特殊气候和人群体质特点,逐渐形成独具风格的岭南医学流派。何梦瑶作为岭南名医之一,其医术高明,医学著作颇丰,极大地促进了岭南医学的发展。; 《医碥》是其代表作之一,亦是其学术思想的精髓,为现代研究何梦瑶学术思想和岭南医家流派的主要古籍。其中所记载的舌诊方法,至今仍具有临床实用意义。Lingnan, Chinese refers to the south of the five ridges area, which is; equivalent to the current Guangdong province, Guangxi province and; Hainan province. All due to the hot and humid climate, majority of local; people are with spleen and stomach deficiency, most of the clinical; manifestation are yang deficiency and dampness. After the Jin dynasty,; based on the traditional Chinese medicine of central plains, the local; doctors gradually formed their unique medical schools, combining with; the characteristics of the local climate and peoples constitutions. As; one of the famous specialists in the south of the five ridges, HE; Meng-yao, greatly promote the development of local medical health level.; Yibian is one of his famous masterpieces, which is also the essence of; the his medicine. Records of tongue diagnosis in this book are still; practical in clinical.国家自然科学基金资助项目; 福建中医药大学校管课题; 福建省科技计划引导性项

Efficacy of Zaozhu Yinchen Recipe for Treating Non-alcoholic Steatohepatitis and Its Effect on Free Fatty Acid and TNF-α

目的观察皂术茵陈方治疗非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)患者的临床疗效,并探讨其对游离脂肪酸(free fatty acid,FFA)及TNF-α的影响。方法采用随机数字表法将120例NASH患者分为治疗组及对照组,每组60例。治疗组予中药皂术茵陈方,每日1剂;对照组予水飞蓟宾葡甲胺片200 mg口服,每日3次,两组均治疗24周。分别于治疗前后通过检测血清ALT、AST活性及TC、TG水平;行腹部CT计算肝脾CT比值;应用肝组织病理检查评价非酒精性脂肪性肝病活动度积分(NAFLD activity score,NAS)及纤维化程度以评价临床疗效;并检测血清FFA及TNF-α含量。结果与本组治疗前比较,两组治疗后血清ALT、AST、TC、TG、FFA、TNF-α水平、肝组织NAS积分及症状体征积分均明显降低,肝纤维化程度明显改善(P<0.05,P<0.01),且治疗组降低更明显(P<0.05)。治疗24周后,治疗组肝纤维化分期总有效率及临床总有效率分别为80.00%(48/60)、85.00%(51/60),明显高于对照组[60.00%(36/60)、73.33%(44/60)],两组比较,差异有统计学意义(P<0.05,P<0.01)。结论皂术茵陈方可改善NASH患者的临床疗效,其作用可能与抑制血清FFA及TNF-α水平有关。Objective To observe the efficacy of Zaozhu Yinchen Recipe(ZZYCR) on non-alcoholic steatohepatitis(NASH) patients, and to explore its effect on serum free fatty acid(FFA) and tumor necrosis factor α(TNF-α).Methods Totally 120 patients with NASH were randomly assigned to the treatment group(60 cases,treated with ZZYCR, one dose per day) and the control group(60 cases, treated with Silibin Meglumine Tablets, 20 mg each time, thrice per day). The therapeutic course for all was 24 weeks. Serum levels of ALT and AST activities, TC and TG levels were detected before and after treatment. Peritoneal CT was performed in all patients, and CT ratios of liver and spleen calculated. NAFLD activity score(NAS) and degree of hepatic fibrosis were assessed using pathological examinations of liver tissue, and efficacy also evaluated. Serum contents of FFA and TNF-αwere also detected. Results Compared with before treatment in the same group, activities of ALT and AST, serum levels of TC, TG, FFA, and TNF-α, NAS, scores of symptoms and signs all obviously decreased, degree of hepatic fibrosis was obviously improved in the two groups(P < 0. 05, P < 0. 01). These changes were more obviously seen in the treatment group(P < 0. 05). After 24-week treatment, the total effective rate and total clinical efficacy were 80. 00%(48/60 cases) and 85. 00%(51/60 cases) in the treatment group, obviously higher than those in the control group [60. 00%(36/60 cases) and 73. 33%(44/60 cases) respectively], with significant difference(P < 0. 05, P < 0. 01). Conclusion ZZYCR could improve the clinical efficacy of NASH patients, and its mechanism might be associated with inhibiting serum levels of FFA and TNF-α.国家自然科学基金资助项目(No.81503529,81274155);; 福建省自然科学基金面上资助项目(No.2014J01374);; 福建省卫生厅中医药项目(No.wzpw201308);; 厦门市科技计划项目(No.3502Z20134020

Direct experimental evidence for detailed growth of SiO_x nanowire during CVD

在纳米线的制备中,气-液-固(VlS)生长机制得到了人们的广泛认可,但该机制的很多细节还停留在模型阶段.依托实验室自行设计的一台生长条件高度可控的高温化学气相沉积(CVd)系统,采用较为简便的方法,直接在SI片衬底上制备出了SIOX纳米线.通过严格控制实验参数,用离位观测捕捉到了纳米线的催化、形核和长大的一系列过程及其相关细节,并发现纳米线从细到粗的气-液-固(VlS)生长机制.讨论了气-液-固(VlS)机制中气态SI原子的来源以及纳米线的催化、形核和长大过程中的纳米曲率效应和“纳米熟化“现象,取得了对SIOX纳米线VlS催化生长机制的理解的突破.Among the mechanisms for nanowire growths, the vapor-liquid-solid (VLS) mechanism is the most widely accepted.Nevertheless, the growth process and relevant details for the VLS mechanism are not yet fully understood for the complicated nano processes involved.In the present article, with a precise control of temperature, gas flow, pressure, and reaction periods in a home- built high-temperature chemical vapor deposition (CVD) system, detailed processes of catalyzing, nucleation, and growth of the SiOx nanowires and a stepwise non uniformity in diameter of nano- wire were successfully traced.With analysis of these experimental results via nanocurvature and nano ripening effects, a further understanding of the vapor-liquid-solid mechanism, especially the mechanism for formation of the stepwise non uniformity in diameter of nanowires, was achieved for the first time.国家科技计划国际科技合作与交流专项(编号:2008DFA51230);国家重点基础研究发展计划(编号:2007CB936603);国家自然科学基金(批准号:60776007、90401022);中澳科技合作特别基金(编号:20050222);教育部科技重点项目(编号:105099)资

PCR-探针熔解分析法检测结核分枝杆菌氟喹诺酮耐药基因突变的临床应用评价

目的评价PCR-探针熔解分析法(PMAA)检测结核分枝杆菌(MTB)氟喹诺酮(FQ)药物耐药性的临床应用价值。方法采用常规比例法和PCR-PMAA对509株MTB临床分离株进行FQ药物敏感性试验。对69株比例法和(或)PCR-PMAA法检测耐药以及440株两法检测均敏感的MTB菌株中抽取的55株菌株,进行FQ药物耐药相关基因gyrA和gyrBPCR-DNA测序。结果以常规比例法为标准,PCR-PMAA检测FQ药物耐药性的敏感性、特异性、阳性和阴性预测值、符合率及约登指数分别为97.01%、99.55%、97.01%、99.55%、99.21%及0.97。比例法和(或)PCR-PMAA检测耐药的69株中,经DNA测序证实44株gyrA94位密码子GAC→AAC(D→N)或CAC(H)或GGC(G)或GCC(A)突变;4株gyrA91位密码子TCG→CCG(S→P)突变;19株gyrA90位密码子GCG→GTG(A→V)或AAG(K)突变;1株gyrB500位GAC→AAC(D→N)突变;1株在测序范围未见突变。55株两法检测均敏感样品DNA测序结果证实,gyrA和gyrB基因均未见耐药相关的基因位点突变。结论 PCR-PMAA法能高效检出MTBFQ药物耐药相关基因突变,用于检测MTBFQ药物耐药性敏感性高,特异性强,方法简便、快速、价廉,具有良好的临床应用前景